LONDON, July 16 (Reuters) - Swiss biotech company Asceneuron said on Tuesday it had raised $100 million from investors including the controlling shareholder of Wegovy maker Novo Nordisk to fund clinical development of its Alzheimer's disease drug. The Series C round was led by Novo Holdings, the investment arm of the Novo Nordisk Foundation, which will hold a board seat...

03:29 AM EDT, 07/16/2024 (MT Newswires) -- Heather Campe, Senior Vice President, International Growth, on July 12, 2024, sold 23,696 shares in H B Fuller ( FUL ) for $1,958,763. Following the Form 4 filing with the SEC, Campe has control over a total of 19,742 shares of the company, with 19,742 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/39368/000122520824007434/xslF345X03/doc4.xml Price: 81.76,...

03:27 AM EDT, 07/16/2024 (MT Newswires) -- Spencer Burton, President and Chief Operating Officer, on July 11, 2024, sold 10,618 shares in Ensign Group ( ENSG ) for $1,437,438. Following the Form 4 filing with the SEC, Burton has control over a total of 42,629 shares of the company, with 42,629 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1125376/000112537624000128/xslF345X03/wk-form4_1721086634.xml Price: 135.22, Change:...

03:25 AM EDT, 07/16/2024 (MT Newswires) -- Jeff Horing, 10% Owner, Director, on July 11, 2024, sold 6,219,839 shares in nCino (NCNO) for $193,246,817. Following the Form 4 filing with the SEC, Horing has control over a total of 19,771,487 shares of the company, with 117,603 shares held directly and 19,653,884 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1902733/000110465924079981/xslF345X03/tm2419507-4_4seq1.xml ...